glp 1 and autoimmune disorders The Thyroid Twist: How GLP-1 Agonists Are Influencing Thyroid Care Exploring glucagon-like peptide-1 receptor agonists
Description
[DOI] [PubMed] [Google Scholar] 17.Newsome P., Francque S., Harrison S., Ratziu V., Van Gaal L., Calanna S., et al
A qualified healthcare provider should evaluate your medical history, comorbidities, and individual risk factors before recommending long-term treatment
More than 40% of respondents who have diabetes and about a quarter of those who have heart disease said they have used GLP-1 drugs
Zealand Pharma regains worldwide rights to Amylin analog program from Boehringer Ingelheim (2020)
Sensitivity analyses generally supported the primary findings
doi: 10.1097/WNR.0b013e32832fbf14 [DOI] [PubMed] [Google Scholar] 67
